Acalabrutinib is a drug used to treat non-Hodgkin's lymphoma (called set cell lymphoma). In particular, this applies to people who have been previously treated with another therapy
| API&Intermediates | CAS | Structural formula | Drug | Minimum order quantity | |
|---|---|---|---|---|---|
| 1 | Acalabrutinib | 1420477-60-6 |
|
API | 5g |
| 2 | 1-Pyrrolidinecarboxylic acid, 2-(8-amino-1-bromoimidazo[1,5- | 1420478-88-1 |
|
Intermediate | 5g |
